XML 72 R60.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Information (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]        
Total Revenue $ 0 $ 0 $ 0 $ 16,020,000
Less: Significant and Other Segment Expenses        
General and Administrative 1,443,827 1,380,997 4,287,075 4,215,411
Research and Development 2,729,891 2,184,991 7,852,267 5,917,868
KIO-301 Collaboration Credit (1,658,248) (867,760) (5,310,288) (2,200,298)
In-Process R&D Impairment 0 2,008,000 0 2,008,000
Change in Fair Value of Contingent Consideration (1,721,033) (1,103,991) (1,308,067) (995,951)
Income Tax Benefit (643,129) 0 (632,179) 0
Net (Loss) Income 26,806 (3,413,326) (4,318,633) 7,818,235
Reportable Segment        
Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items]        
Total Revenue 0 0 0 16,020,000
Less: Significant and Other Segment Expenses        
General and Administrative 1,443,827 1,380,997 4,287,075 4,215,411
KIO-301 Collaboration Credit (1,658,248) (867,760) (5,310,288) (2,200,298)
In-Process R&D Impairment 0 2,008,000 0 2,008,000
Change in Fair Value of Contingent Consideration (1,721,033) (1,103,991) (1,308,067) (995,951)
Interest Income, Net (201,822) (248,840) (703,692) (813,989)
Other Segment Expenses 23,708 59,929 133,517 70,724
Income Tax Benefit (643,129) 0 (632,179) 0
Net (Loss) Income 26,806 (3,413,326) (4,318,633) 7,818,235
KIO-101 | Reportable Segment        
Less: Significant and Other Segment Expenses        
Research and Development 11,223 8,525 18,017 21,609
KIO-104 | Reportable Segment        
Less: Significant and Other Segment Expenses        
Research and Development 255,085 611,722 532,106 637,619
KIO-201 | Reportable Segment        
Less: Significant and Other Segment Expenses        
Research and Development 0 0 0 30,875
KIO-301 | Reportable Segment        
Less: Significant and Other Segment Expenses        
Research and Development 2,057,678 743,842 6,285,162 2,850,958
Unallocated R&D Expenses | Reportable Segment        
Less: Significant and Other Segment Expenses        
Research and Development $ 405,905 $ 820,902 $ 1,016,981 $ 2,376,807